TRIM27 is a new negative regulator of CD4 T cells and Mast cells.
TRIM27 is a new negative regulator of CD4 T cells and Mast cells.
批准号:
8875012
负责人:
EDWARD Y SKOLNIK
金额:
$32.96万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-01-15 至 2017-06-30
关键词:
1-Phosphatidylinositol 3-KinaseAffectAnaphylaxisApplications GrantsAsthmaAutoimmune DiseasesB-Cell ActivationBoxingCD4 Positive T LymphocytesCalcium-Activated Potassium ChannelCellsCoiled-Coil DomainCutaneousDevelopmentFailureFeedbackFingersGenerationsGoalsGraft RejectionHelper-Inducer T-LymphocyteHistidineHumanHypersensitivityImmune systemIn VitroInflammationLeadLymphocyteLysineMediatingMusNamesNucleoside diphosphate kinase BPathway interactionsPhosphoric Monoester HydrolasesPhosphotransferasesPhysiologicalPotassium ChannelProtein FamilyProteinsReceptor ActivationRecruitment ActivityRegulationRegulatory T-LymphocyteRoleSignal PathwaySignaling MoleculeStructure of thyroid parafollicular cellT-Cell ActivationT-Cell ReceptorT-LymphocyteT-Lymphocyte SubsetsTRIM MotifTh1 CellsUbiquitinationallergic responsefollow-upimmunological synapseimmunological synapse formationin vivoinhibitor/antagonistinsightmast cellmembermyotubularinphosphatidylinositol 3-phosphatephosphohistidinepreventprotein-histidine kinaseresponseubiquitin-protein ligase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The K+ channel KCa3.1 is required for Ca2+ influx and the subsequent activation of B, T, and mast cells. Our studies have found that T cell receptor (TCR) activation leads to activation of KCa3.1 by activating the class 2 phosphatidylinositol 3 kinase C2 Beta (PI3K-C2ß) leading to the generation of PI3P, which is required for the subsequent activation of a mammalian histidine kinase, Nucleoside Diphosphate Kinase B, that then activates KCa3.1. We identified the Tripartate Motif containing protein 27 (TRIM27) as a new negative regulator of PI3K-C2ß and KCa3.1. TRIM27 is a member of a large family of proteins characterized by the presence of a tripartite motif, consisting of a RING finger, B box, and coiled coil (CC) domains. In this proposal, we will determine the mechanisms whereby TRIM27 regulates PI3K-C2ß, its physiological significance, and subsequent role as a negative regulator of KCa3.1 in lymphocyte and mast cell activation in vitro and in vivo. We have evidence that TRIM27 functions an E3 ligase and ubiquitinates and inhibits PI3K-C2ß. To determine the mechanism(s) whereby TRIM27 regulates PI3K-C2ß and how this is affected by TCR activation, we will determine in SA1, (Ai) the type of TRIM27 mediated ubiquitination of PI3K-C2ß; (Aii) the lysine residues on TRIM27 and PI3K-C2ß that are ubiquitinated; and (Aiii) the regions or domains on TRIM27 and PI3K-C2ß that mediate their association. In 1B, we will determine: (Bi) if TRIM27 regulates TCR stimulated PI3K-C2ß's kinase activity and/or degradation, or whether (Bii) association of TRIM27 with PI3K-C2ß is affected by TCR stimulation; (Biii) whether TRIM27 is recruited to the immunological synapse (IS), its role in IS formation and/or the recruitment PI3K-C2ß to IS following TCR activation; (Biv) whether TRIM27 modulates the PI3P levels in activated T cells, or (Bv) whether TRIM27 autoubiquitination, or ubiquitination of PI3K-C2ß is modulated by TCR stimulation. In (C), the role of TRIM27 stimulated SUMOylation of PI3K-C2ß will be assessed. We have generated TRIM27-/- mice and have evidence that KCa3.1 channel activity and TCR- stimulated Ca2+ flux are increased in TRIM27-/- Th1 cells. In SA2 (A), we will extend these studies to other CD4 helper T cell subsets, and determine whether Th2, Th17, and Treg differentiation and/or function are altered in cells isolated from TRIM27-/- mice. In (B), we will determine the downstream signaling pathways regulated by TRIM27, and (C) whether TRIM27-/- mice are predisposed to autoimmune disease. In (D) we will undertake a nonbiased approach to identify other targets of TRIM27 ubiquitination and regulation We found that TRIM27 functions to negatively regulate FceR1 stimulated KCa3.1 channel activity and Ca2+ flux in mast cells. We will determine in SA3: (A) if PI3K-C2ß mediates FceR1 stimulated activation of KCa3.1 and whether this is modulated by TRIM27; (B) whether effectors functions of TRIM27-/- mast cells are increased; (3C) the signaling pathways regulated by TRIM27 in mast cells, and/or (3D) whether TRIM27-/- mice have an increased anaphylactic response to both passive cutaneous and systemic anaphylaxis.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1091/mbc.e13-04-0180
发表时间:
2014-04
期刊:
Molecular biology of the cell
影响因子:
3.3
作者:
[Cai X, Srivastava S, Surindran S, Li Z, Skolnik EY]
通讯作者:
Skolnik EY
DOI:
10.1161/atvbaha.114.304239
发表时间:
2014-10-01
期刊:
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
影响因子:
8.7
作者:
[Feng, Yuxi, Gross, Shalini, Wieland, Thomas]
通讯作者:
Wieland, Thomas
Identification of new therapeutic targets for ADPKD
-
批准号:10462701
-
项目类别:
-
资助金额:$50.82万
-
财政年份:2021
-
负责人:EDWARD Y SKOLNIK
-
依托单位:
Identification of new therapeutic targets for ADPKD
-
批准号:10629396
-
项目类别:
-
资助金额:$50.82万
-
财政年份:2021
-
负责人:EDWARD Y SKOLNIK
-
依托单位:
Identification of new therapeutic targets for ADPKD
-
批准号:10298937
-
项目类别:
-
资助金额:$50.82万
-
财政年份:2021
-
负责人:EDWARD Y SKOLNIK
-
依托单位:
Histidine Phosphorylation in Mammals: Regulation, Protein Targets, and Biology
-
批准号:10395477
-
项目类别:
-
资助金额:$39.83万
-
财政年份:2019
-
负责人:EDWARD Y SKOLNIK
-
依托单位:
Histidine Phosphorylation in Mammals: Regulation, Protein Targets, and Biology
-
批准号:10152661
-
项目类别:
-
资助金额:$39.83万
-
财政年份:2019
-
负责人:EDWARD Y SKOLNIK
-
依托单位:
Identification and characterization of a novel mammalian histidine phosphatase that negatively regulates CD4 T cells
-
批准号:9330534
-
项目类别:
-
资助金额:$54.79万
-
财政年份:2016
-
负责人:EDWARD Y SKOLNIK
-
依托单位:
TRIM27 is a new negative regulator of CD4 T cells and Mast cells.
-
批准号:8667953
-
项目类别:
-
资助金额:$15.22万
-
财政年份:2013
-
负责人:EDWARD Y SKOLNIK
-
依托单位:
New Signaling pathways that positively and negatively regulate CD4 T cells via th
-
批准号:8742789
-
项目类别:
-
资助金额:$15.48万
-
财政年份:2013
-
负责人:EDWARD Y SKOLNIK
-
依托单位:
TRIM27 is a new negative regulator of CD4 T cells and Mast cells.
-
批准号:8541082
-
项目类别:
-
资助金额:$4.34万
-
财政年份:2012
-
负责人:EDWARD Y SKOLNIK
-
依托单位:
TRIM27 is a new negative regulator of CD4 T cells and Mast cells.
-
批准号:8218480
-
项目类别:
-
资助金额:$32.96万
-
财政年份:2012
-
负责人:EDWARD Y SKOLNIK
-
依托单位:
TRIM27 is a new negative regulator of CD4 T cells and Mast cells.
-
批准号:8599475
-
项目类别:
-
资助金额:$32.96万
-
财政年份:2012
-
负责人:EDWARD Y SKOLNIK
-
依托单位:
TRIM27 is a new negative regulator of CD4 T cells and Mast cells.
-
批准号:8412757
-
项目类别:
-
资助金额:$31.8万
-
财政年份:2012
-
负责人:EDWARD Y SKOLNIK
-
依托单位:
The Role of the Calcium Activated Potassium Channel, KCa3.1, in the Pathogenesis
-
批准号:7988625
-
项目类别:
-
资助金额:$11.41万
-
财政年份:2010
-
负责人:EDWARD Y SKOLNIK
-
依托单位:
New signaling pathways that positively and negatively regulate CD4 T cells via th
-
批准号:7637286
-
项目类别:
-
资助金额:$4.24万
-
财政年份:2008
-
负责人:EDWARD Y SKOLNIK
-
依托单位:
New signaling pathways that positively and negatively regulate CD4 T cells via th
-
批准号:8284449
-
项目类别:
-
资助金额:$41.53万
-
财政年份:2008
-
负责人:EDWARD Y SKOLNIK
-
依托单位:
New signaling pathways that positively and negatively regulate CD4 T cells via th
-
批准号:8090261
-
项目类别:
-
资助金额:$31.15万
-
财政年份:2008
-
负责人:EDWARD Y SKOLNIK
-
依托单位:
New signaling pathways that positively and negatively regulate CD4 T cells via th
-
批准号:7440587
-
项目类别:
-
资助金额:$4.24万
-
财政年份:2008
-
负责人:EDWARD Y SKOLNIK
-
依托单位:
New signaling pathways that positively and negatively regulate CD4 T cells via th
-
批准号:7894642
-
项目类别:
-
资助金额:$4.2万
-
财政年份:2008
-
负责人:EDWARD Y SKOLNIK
-
依托单位:
The Role of the Calcium Activated Potassium Channel, KCa3.1, in the Pathogenesis
-
批准号:7298364
-
项目类别:
-
资助金额:$29.58万
-
财政年份:2007
-
负责人:EDWARD Y SKOLNIK
-
依托单位:
The Role of the Calcium Activated Potassium Channel, KCa3.1, in the Pathogenesis
-
批准号:7484997
-
项目类别:
-
资助金额:$16.61万
-
财政年份:2007
-
负责人:EDWARD Y SKOLNIK
-
依托单位:
海外基金